tlooto
Sign up
Medicine

Response to ‘Reassessing the Clinical Interpretation of Atezolizumab Plus Bevacizumab in Child–Pugh B Hepatocellular Carcinoma’

R. Sasaki, S. Shimose, I. Saeki, H. Miyaaki

2026.2.6LIVER INTERNATIONAL

DOI: 10.1111/liv.70547

Abstract

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Citation format

SASAKI, R., et al. Response to ‘reassessing the clinical interpretation of atezolizumab plus bevacizumab in child–pugh b hepatocellular carcinoma’. LIVER INTERNATIONAL, 2026, 46(3): e70547.